Extension study of an RCT by Emery et al. [156] in which participants who had initiated ART during acute HIV infection received placebo or rFPV±human IFN-γ; in this extension study, participants received a booster and then underwent ATI one week later. Here, IFNG is linked to HIV infectious disease.